RF Acquisition Corp II shareholders approve Nanyang Biologics deal; 3.96M shares seek redemption

RF Acquisition Corp II

All six proposals approved at Aug 19 EGM: 6,765,584 for, 440,604 against, 0 abstain.
Preliminary redemption requests for 3,956,323 ordinary shares from trust account (~47.4% of outstanding).
Business combination with Nanyang Biologics Pte. Ltd. via NYB Holdings remains subject to closing conditions.
Quorum of 7,206,188 shares (86.36%) present; record date May 20, 2026.
Redemption requests may be withdrawn with consent; final per-share price and trust proceeds pending closing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.